ACET

Adicet Bio, Inc.

ACET | $1.95 -3.7% -3.85% 730K

(0.0% 1d) (-4.4% 1m) (-68.4% 1y) (0.0% 2d) (-14.1% 3d) (-11.4% 7d) (-4.34% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 160,230,726
http://www.adicetbio.com
Sec Filling | Patents | 18 employees

(US) Adicet Bio, Inc. is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

cancer t-cell ceiling

add to watch list Paper trade email alert is off

Press-releases

Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -13.33% | O: -1.33% H: 1.8% C: -1.8%
conference

Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| 0.0% | O: 1.03% H: 4.57% C: 3.05%
company year financial results

Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -19.75% | O: 0.0% H: 3.29% C: 1.23%
conference cell therapy

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - March 01, 2024
Published: 2024-03-01 (Crawled : 08:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -17.02% | O: 0.43% H: 2.12% C: 1.69%
nasdaq grant

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -35.0% | O: -1.33% H: 5.41% C: 5.41%
conference

Adicet Bio, Inc. Announces Pricing of Public Offering - Jan 23, 2024
Published: 2024-01-23 (Crawled : 06:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -23.23% | O: 2.95% H: 0.0% C: 0.0%
offering

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
Published: 2024-01-04 (Crawled : 13:30) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| -3.47% | O: -0.99% H: 18.5% C: 8.0%
update

Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
Published: 2023-10-04 (Crawled : 20:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| 50.0% | O: -0.77% H: 0.78% C: 0.0%
conference presentation cancer therapeutics molecular

Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-09-27 (Crawled : 14:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K

Health Technology

| 36.36% | O: 0.7% H: 4.86% C: 0.0%
cancer cell immunotherapy meeting platform

Adicet Announces Appointment of Katie Peng to the Board of Directors
Published: 2023-07-11 (Crawled : 13:00) - biospace.com/
DNLI | $15.98 -3.74% -3.88% 1.5M

Health Technology